Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Cheap Dividend Stocks That Smart Investors Will Snap Up Now

Those looking for passive income won’t have to pay full price with these cheap dividend stocks for smart investors to consider.

Credit Rating Alert: Why Did Fitch Downgrade U.S. Debt?

Sentiment on Wall Street flashed red as credit rating agency Fitch downgraded the U.S. debt rating, highlighting stability concerns.

AURC Stock Shoots Higher Again Ahead of Better.com Merger

Although speculation runs hot for Aurora Acquisition and its upcoming merger vote with Better.com, AURC stock presents high risks.

Women’s World Cup 2023: 3 Surprising Stocks That Are Set to Score Big-Time

With an expanded field and fresh storylines, the tournament undergirding Women’s World Cup 2023 stocks could be good for business.

7 Cryptos to Watch as Regulators, Fed Weigh Heavily

Although cryptos have been resilient, the double headwind of regulatory pressure and tightening monetary policy warrants caution.

7 Boring Stocks That Can Thrive When Interest Rates Rise

With the Federal Reserve forced to think big picture about its policies, investors should consider these reliable stocks during rate hikes.

The Top 3 Stocks to Buy TOMORROW

If you’re short on time and need to see some profits right away, these stocks to buy tomorrow just might fit the bill.

LI Stock Alert: Li Auto Vehicle Deliveries Are Up 227%

Although Li Auto has been a fast mover this year, its impressive delivery haul for July continues to undergird sentiment for LI stock.

Why Is TG Therapeutics (TGTX) Stock Down 50% Today?

Although anticipation ran hot for TG Therapeutics’ flagship MS therapeutic, a disappointing Q2 print cratered TGTX stock.

Bad News Will Actually Be a Boost for These 3 Troubled Tech Stocks

Although troubled entities should usually be left alone, these tech stocks rising from adversity may intrigue contrarians.